These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 37111333)
1. Synthesis, In Silico and In Vitro Characterization of Novel Park J; Wasim S; Jung JH; Kim MH; Lee BC; Alam MM; Lee SY Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111333 [TBL] [Abstract][Full Text] [Related]
2. Novel potential pyrazolopyrimidine based translocator protein ligands for the evaluation of neuroinflammation with PET. Kwon YD; Kang S; Park H; Cheong IK; Chang KA; Lee SY; Jung JH; Lee BC; Lim ST; Kim HK Eur J Med Chem; 2018 Nov; 159():292-306. PubMed ID: 30296688 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714. Cacheux F; Médran-Navarrete V; Dollé F; Marguet F; Puech F; Damont A Eur J Med Chem; 2017 Jan; 125():346-359. PubMed ID: 27688189 [TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of novel pyrazolo[1,5-a]pyrimidine acetamides, closely related to DPA-714, as potent ligands for imaging the TSPO 18kDa with PET. Médran-Navarrete V; Damont A; Peyronneau MA; Kuhnast B; Bernards N; Pottier G; Marguet F; Puech F; Boisgard R; Dollé F Bioorg Med Chem Lett; 2014 Mar; 24(6):1550-6. PubMed ID: 24560538 [TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation. Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide. Hieu Tran V; Park H; Park J; Kwon YD; Kang S; Ho Jung J; Chang KA; Chul Lee B; Lee SY; Kang S; Kim HK Bioorg Med Chem; 2019 Sep; 27(18):4069-4080. PubMed ID: 31353076 [TBL] [Abstract][Full Text] [Related]
7. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization. James ML; Fulton RR; Vercoullie J; Henderson DJ; Garreau L; Chalon S; Dolle F; Costa B; Guilloteau D; Kassiou M J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395 [TBL] [Abstract][Full Text] [Related]
8. Derivatives of the pyrazolo[1,5-a]pyrimidine acetamide DPA-713 as translocator protein (TSPO) ligands and pro-apoptotic agents in human glioblastoma. Werry EL; King VA; Barron ML; Banister SD; Sokias R; Kassiou M Eur J Pharm Sci; 2017 Jan; 96():186-192. PubMed ID: 27658888 [TBL] [Abstract][Full Text] [Related]
9. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide. Tang D; Hight MR; McKinley ET; Fu A; Buck JR; Smith RA; Tantawy MN; Peterson TE; Colvin DC; Ansari MS; Nickels M; Manning HC J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging. Tang D; McKinley ET; Hight MR; Uddin MI; Harp JM; Fu A; Nickels ML; Buck JR; Manning HC J Med Chem; 2013 Apr; 56(8):3429-33. PubMed ID: 23521048 [TBL] [Abstract][Full Text] [Related]
11. Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO). Banister SD; Beinat C; Wilkinson SM; Shen B; Bartoli C; Selleri S; Da Pozzo E; Martini C; Chin FT; Kassiou M Eur J Med Chem; 2015 Mar; 93():392-400. PubMed ID: 25725375 [TBL] [Abstract][Full Text] [Related]
12. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [¹⁸F]DPA-714. Abourbeh G; Thézé B; Maroy R; Dubois A; Brulon V; Fontyn Y; Dollé F; Tavitian B; Boisgard R J Neurosci; 2012 Apr; 32(17):5728-36. PubMed ID: 22539835 [TBL] [Abstract][Full Text] [Related]
13. New structure-activity relationships of N-acetamide substituted pyrazolopyrimidines as pharmacological ligands of TSPO. Li J; Schulte ML; Nickels ML; Manning HC Bioorg Med Chem Lett; 2016 Aug; 26(15):3472-7. PubMed ID: 27353534 [TBL] [Abstract][Full Text] [Related]
14. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. Lavisse S; Guillermier M; Hérard AS; Petit F; Delahaye M; Van Camp N; Ben Haim L; Lebon V; Remy P; Dollé F; Delzescaux T; Bonvento G; Hantraye P; Escartin C J Neurosci; 2012 Aug; 32(32):10809-18. PubMed ID: 22875916 [TBL] [Abstract][Full Text] [Related]
15. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images. Damont A; Médran-Navarrete V; Cacheux F; Kuhnast B; Pottier G; Bernards N; Marguet F; Puech F; Boisgard R; Dollé F J Med Chem; 2015 Sep; 58(18):7449-64. PubMed ID: 26280386 [TBL] [Abstract][Full Text] [Related]